Company Overview
MONTE ROSA THERAPEUTICS, INC.
GLUERevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-39M
2025 FY
Shares Outstanding
83M
2025 FY
EPS
USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1826457
Exchange
Nasdaq
Location
US